Jiang Lin, Zheng Wei-Hui, Chen Chao
The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital) Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences Hangzhou China.
Key Laboratory of Head and Neck Cancer Translational Research of Zhejiang Province Hangzhou China.
Laryngoscope Investig Otolaryngol. 2022 May 17;7(3):894-900. doi: 10.1002/lio2.805. eCollection 2022 Jun.
Carcinoma showing thymus-like elements (CASTLE) is a rare kind of malignant tumor of thyroid gland. The genetic mutation characteristics of CASTLE are not clear.
We retrospectively analyzed seven patients diagnosed as CASTLE tumor in our hospital, and performed whole exome sequencing (WES) in five cases to analyze the genomic variation of CASTLE in thyroid gland.
The diagnosis of CASTLE was confirmed by histopathological and immunohistochemical results. Immunohistochemical staining showed that cell membranes of tumor samples in all cases were moderately to strongly positive for CD5 and CD117. WES presented a large number of single nucleotide variants (SNVs), insertions and deletions (InDel), and copy number variations (CNVs). By comparing with the TCGA database, we found novel mutations in significantly mutated genes such as , , , , and , as well as in potential disease-related driver genes such as , , , , , , , , and
CASTLE tumors contain unique tumor driver gene mutations. The information about mutations in several novel genes obtained in this study may contribute to unraveling the molecular mechanisms responsible for the emergence of thyroid CASTLE tumors and help formulating possible in-roads for treatment.
甲状腺类癌(CASTLE)是一种罕见的甲状腺恶性肿瘤。CASTLE的基因突变特征尚不清楚。
我们回顾性分析了我院诊断为CASTLE肿瘤的7例患者,并对其中5例进行了全外显子组测序(WES),以分析甲状腺中CASTLE的基因组变异。
组织病理学和免疫组化结果证实为CASTLE。免疫组化染色显示,所有病例肿瘤样本细胞膜CD5和CD117呈中度至强阳性。WES呈现出大量单核苷酸变异(SNV)、插入缺失(InDel)和拷贝数变异(CNV)。通过与TCGA数据库比较,我们在 、 、 、 、 等显著突变基因以及 、 、 、 、 、 、 、 等潜在疾病相关驱动基因中发现了新的突变。
CASTLE肿瘤包含独特的肿瘤驱动基因突变。本研究获得的几个新基因的突变信息可能有助于阐明甲状腺CASTLE肿瘤发生的分子机制,并有助于制定可能的治疗途径。